Finally, the potential tumorigenicity of glioblastoma cells may also be affected by recruitment of EZH2 (a subunit of the Polycomb Repressive Complex 2) to the NKD1 promoter by H19, with its repression positively contributing to glioblastoma tumorigenicity [182]. This evidence concerns the gene H19 and glioblastoma.